剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

交易中 06-18 15:53:35

14.470

-0.060

-0.41%

最高14.900	最低14.080	成交量116.51万
今开14.530	昨收14.530	日振幅5.64%
总市值171.18亿	流通市值156.71亿	总股本11.83亿
成交额1,702万	换手率0.11%	流通股本10.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":14.47,"timestamp":1781769182679,"preClose":14.53,"halted":0,"volume":1165102,"delay":0,"changeRate":-0.00412938747419124,"floatShares":1083000000,"shares":1183000000,"eps":-4.824642244729542,"marketStatus":"交易中","change":-0.06,"latestTime":"06-18 15:53:35","open":14.53,"high":14.9,"low":14.08,"amount":17021904,"amplitude":0.056435,"askPrice":14.52,"askSize":3500,"bidPrice":14.47,"bidSize":2500,"shortable":0,"etf":0,"ttmEps":-0.42524634398658295,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781770200000},"marketStatusCode":2,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":14.53,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":0.263343,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"2642325034","title":"港股异动 | 剂泰科技-P(07666)最高涨近7% 近日正式发布AiProtein平台及抗体设计智能体AARON","url":"https://stock-news.laohu8.com/highlight/detail?id=2642325034","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642325034?lang=zh_cn&edition=full","pubTime":"2026-06-12 14:55","pubTimestamp":1781247352,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P最高涨近7%，截至发稿，涨4.36%，报13.4港元，成交额2171.54万港元。消息面上，近日，据剂泰科技官微消息，公司正式发布AiProtein平台以及抗体设计智能体AARON。AiProtein采用剂泰科技自研“干实验+湿实验+智能体”创新范式，是聚焦蛋白和抗体等大分子的设计平台。作为剂泰科技AI纳米递送平台NanoForge驱动下的第四大核心解决方案，AiProtein与AiLNP、AiRNA和AiTEM共同完成了从蛋白设计、mRNA序列设计和LNP设计的剂泰科技“火箭+卫星”端到端研发闭环。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","BK4588","07666","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103193776","title":"异动解读｜剂泰科技-P盘中下跌5.26%，超额配发股份上市流通次日抛压持续释放","url":"https://stock-news.laohu8.com/highlight/detail?id=1103193776","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103193776?lang=zh_cn&edition=full","pubTime":"2026-06-11 10:47","pubTimestamp":1781146078,"startTime":"0","endTime":"0","summary":"6月11日，剂泰科技-P盘中下跌5.26%，报11.53港元，成交额1891.85万港元。该股自5月13日上市首日大涨173%后持续回调，较首日高点回撤显著。消息面上，公司超额配股权已悉数行使，涉及3018.4万股H股按发售价10.50港元发行，该批股份于6月10日正式上市交易，新增流通股供给加大市场抛压。同时，稳定价格期间已于6月7日结束，此前支撑股价的稳定价格机制正式退出，叠加部分国际配售股份未设禁售期，获利了结压力持续释放。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107549508","title":"剂泰科技-P：6月10日发行30,184,000股 普通股，占已发行股本约2.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107549508","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107549508?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:22","pubTimestamp":1781086935,"startTime":"0","endTime":"0","summary":"剂泰科技(北京)股份有限公司（“剂泰科技-P”，股票代码：07666）6月10日发布翌日披露报表，宣布公司根据此前公告所述的超额配股权已于当日悉数行使，共发行及配发30,184,000股H股普通股。\n本次发行股份占发行前公司已发行股本约2.8667%，每股发行价格为10.5港元。上述发行完成后，公司已发行股本由1,052,926,111股增至1,083,110,111股。\n公司董事会确认，本次发行已获正式授权并遵守相关法规及上市规定。公告由董事会主席、执行董事兼首席执行官赖才达签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"剂泰科技-P：6月10日发行30,184,000股 普通股，占已发行股本约2.87%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447721","title":"剂泰科技-P(07666)根据悉数行使超额配股权而发行3018.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447721","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642447721?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:20","pubTimestamp":1781086827,"startTime":"0","endTime":"0","summary":"智通财经APP讯，剂泰科技-P(07666)发布公告，该公司于2026年6月10日根据悉数行使超额配股权而发行及配发3018.4万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182529402","title":"异动解读｜剂泰科技-P盘中下跌5.49%，超额配发股份正式上市流通加剧抛压","url":"https://stock-news.laohu8.com/highlight/detail?id=1182529402","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182529402?lang=zh_cn&edition=full","pubTime":"2026-06-10 10:33","pubTimestamp":1781058838,"startTime":"0","endTime":"0","summary":"6月10日，剂泰科技-P盘中下跌5.49%，报12.23港元，成交额866.83万港元。该股自5月13日上市首日大涨173%后持续回调。消息面上，公司此前公告超额配股权已悉数行使，涉及3018.4万股H股按发售价10.50港元发行，该批股份于6月10日正式上市交易，新增流通股供给直接加大市场抛压。同时，稳定价格期间已于6月7日结束，此前支撑股价的稳定价格机制正式退出，叠加部分国际配售股份未设禁售期，获利了结压力持续释放，股价承压态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103440354","title":"异动解读｜剂泰科技-P盘中下跌8.18%，稳定价格期间结束叠加超额配发股份即将上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1103440354","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103440354?lang=zh_cn&edition=full","pubTime":"2026-06-08 10:16","pubTimestamp":1780884966,"startTime":"0","endTime":"0","summary":"6月8日，剂泰科技-P盘中下跌8.18%，报13.23港元，成交额1064.59万港元。该股自5月13日上市首日大涨173%后持续回调，较首日高点回撤显著。消息面上，公司于6月5日公告超额配股权已悉数行使，涉及3018.4万股H股，按发售价10.50港元发行，预计6月10日开始上市交易。同时，稳定价格期间已于6月7日结束，意味着此前支撑股价的稳定价格机制正式退出，市场抛压失去对冲。叠加部分国际配售股份未设禁售期，获利了结压力加剧，新股热度加速消退，股价承压态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641129451","title":"剂泰科技-P(07666)：悉数行使超额配股权、稳定价格行动及稳定价格期间结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2641129451","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641129451?lang=zh_cn&edition=full","pubTime":"2026-06-05 18:53","pubTimestamp":1780656810,"startTime":"0","endTime":"0","summary":"智通财经APP讯，剂泰科技-P 发布公告，招股章程所述的超额配股权已于2026年6月5日(星期五)获整体协调人悉数行使，涉及合共3018.4万股H股，占于任何超额配股权获行使前全球发售项下初步可供认购的发售股份总数的15%。超额配发股份将由本公司按每股H股10.50港元发行及配发。联交所已批准超额配发股份上市及买卖。超额配发股份预期于2026年6月10日上午九时正开始于联交所主板上市及买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161807374","title":"剂泰科技-P更新2026年5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1161807374","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161807374?lang=zh_cn&edition=full","pubTime":"2026-06-04 21:32","pubTimestamp":1780579933,"startTime":"0","endTime":"0","summary":"2026年6月4日，剂泰科技(北京)股份有限公司-P发布2026年5月股份变动月报表。报告期内，公司已发行股份结构中包括99,587,739股境内未上市普通股及1,052,926,111股H股，注册股本合计人民币115,251,385。上述股份数量较上月底无新增发行、购回或注销，股本维持稳定。同时，公司拥有首发前购股权计划所授出的股份期权共18,394,870份，报告期内未见行使或变动。公司确认其已符合相关公众持股量要求，报告由公司董事会主席、执行董事兼首席执行官赖才达签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198765054","title":"异动解读｜剂泰科技-P盘中下跌5.22%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1198765054","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198765054?lang=zh_cn&edition=full","pubTime":"2026-06-04 10:23","pubTimestamp":1780539789,"startTime":"0","endTime":"0","summary":"6月4日，剂泰科技-P盘中下跌5.22%，报14.9港元，成交额638.7万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日宣布与Deerfield达成战略联盟并发布AiProtein平台等利好，但新股上市初期市场热度加速消退，股价承压回落态势延续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132882851","title":"异动解读 | 剂泰科技-P盘中大涨5.82% 与全球顶级平台Deerfield达成战略联盟","url":"https://stock-news.laohu8.com/highlight/detail?id=1132882851","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132882851?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:23","pubTimestamp":1780280602,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.82%，引起了市场的广泛关注。消息面上，公司宣布与全球顶级健康投资与创新平台Deerfield Management达成战略联盟，双方将共同开发新一代体内蛋白药物及免疫疗法，并共同推进合作管线产品的全球商业化进程，这一合作显著增强了市场对公司技术实力和未来增长前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137219689","title":"异动解读｜剂泰科技-P盘中上涨5.62%，报15.61港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137219689","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137219689?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:18","pubTimestamp":1780280283,"startTime":"0","endTime":"0","summary":"6月1日，剂泰科技-P盘中上涨5.62%，报15.61港元/股，成交额904.63万港元。剂泰科技-P所在的生物科技行业中，个股中，康方生物涨6.1%，三生制药涨2.65%，信达生物跌1.2%，科伦博泰生物跌2.42%，百济神州跌1.13%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640982211","title":"港股异动 | 剂泰科技-P(07666)涨近5% 与Deerfield达成战略联盟 共同开发AI驱动蛋白药物与体内免疫疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2640982211","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640982211?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:15","pubTimestamp":1780280137,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P涨近5%，截至发稿，涨4.47%，报15.44港元，成交额822.35万港元。消息面上，5月28日，据剂泰科技官微消息，公司宣布与全球顶级健康投资与创新平台Deerfield Management达成战略联盟。Deerfield将就剂泰科技自研AI纳米递送平台NanoForge及其驱动解决方案和核心管线项目在全球临床开发和商务拓展举措方面开展深度合作。其中包括剂泰科技自研AiProtein平台发现并推进至临床前候选药物阶段的一项领先T细胞衔接器项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","AIPO","ARTY","VXUS","07666","BK4585","BK1161","BK4588","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199714740","title":"异动解读 | 剂泰科技-P盘中大跌5.15%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1199714740","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199714740?lang=zh_cn&edition=full","pubTime":"2026-05-29 11:08","pubTimestamp":1780024129,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大跌5.15%，引发了市场关注。消息面上，剂泰科技作为全球AI药物递送第一股于近期登陆港交所，自上市首日大涨后已连续多个交易日回调，较首日高点回撤显著。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日发布AiProtein平台及宣布与Deerfield达成战略联盟等利好，但新股上市初期市场热度加速消退，股价承压回落态势延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133078222","title":"异动解读｜剂泰科技-P盘中下跌5.08%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1133078222","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133078222?lang=zh_cn&edition=full","pubTime":"2026-05-29 11:07","pubTimestamp":1780024043,"startTime":"0","endTime":"0","summary":"5月29日，剂泰科技-P盘中下跌5.08%，报15.31港元，成交额1788.95万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日发布AiProtein平台及宣布与Deerfield达成战略联盟等利好，但新股上市初期市场热度加速消退，股价承压回落态势延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158694986","title":"异动解读 | 剂泰科技-P盘中大跌5.5%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1158694986","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158694986?lang=zh_cn&edition=full","pubTime":"2026-05-28 11:46","pubTimestamp":1779940011,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大跌5.50%，引发市场关注。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价为10.50港元，上市首日曾大涨173%。然而，自上市以来，该股已连续多个交易日回调，较首日高点回撤显著。公司目前尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日发布了AiProtein平台及宣布与Deerfield达成战略联盟等利好消息，但新股上市初期的市场热度正在加速消退，导致股价承压回落态势延续。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136372381","title":"异动解读｜剂泰科技-P盘中下跌5.21%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1136372381","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136372381?lang=zh_cn&edition=full","pubTime":"2026-05-28 11:42","pubTimestamp":1779939749,"startTime":"0","endTime":"0","summary":"5月28日，剂泰科技-P盘中下跌5.21%，报16.37港元，成交额1787.22万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日发布AiProtein平台及宣布与Deerfield达成战略联盟等利好，但新股上市初期市场热度加速消退，股价承压回落态势延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638658966","title":"Deerfield在中国生科公司首个战略联盟，与剂泰科技（07666）共推AI驱动蛋白药物与体内免疫疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2638658966","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638658966?lang=zh_cn&edition=full","pubTime":"2026-05-28 09:12","pubTimestamp":1779930752,"startTime":"0","endTime":"0","summary":"此次合作将整合剂泰科技在AI驱动蛋白工程、体内免疫治疗及可编程生物药领域的差异化技术，与Deerfield在转化医学、临床开发及全球合作方面的深厚产业经验。剂泰科技在全球率先探索精准体内免疫治疗，将和Deerfield共同打造极具差异化优势的创新平台，加速为全球患者开发突破性疗法。期待与剂泰科技团队展开合作，共同推进基于其自主AI平台与下一代递送技术驱动的创新治疗项目开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ARTY","AIPO","07666","CHAT","BK1161","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638757191","title":"港股异动 | 剂泰科技-P(07666)盘中涨超11% 公司发布METiS AiProtein平台和抗体设计智能体AARON","url":"https://stock-news.laohu8.com/highlight/detail?id=2638757191","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638757191?lang=zh_cn&edition=full","pubTime":"2026-05-27 14:30","pubTimestamp":1779863423,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P盘中涨超11%，截至发稿，涨6.96%，报17.51港元，成交额6337.35万港元。消息面上，剂泰科技正式发布AiProtein平台以及抗体设计智能体AARON。作为剂泰科技AI纳米递送平台NanoForge驱动下的第四大核心解决方案，AiProtein与AiLNP、AiRNA和AiTEM共同完成了从蛋白设计、mRNA序列设计和LNP设计的剂泰科技“火箭+卫星”端到端研发闭环。剂泰科技将依托其全球首个AI纳米递送平台NanoForge，为沙砾生物解决新一代细胞治疗药物的递送瓶颈。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","VXUS","BK4585","07666","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163054533","title":"异动解读 | 剂泰科技-P盘中大涨5.01%，澄清未收到中证监补充资料要求提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1163054533","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163054533?lang=zh_cn&edition=full","pubTime":"2026-05-27 10:34","pubTimestamp":1779849287,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.01%，引起了市场的广泛关注。消息面上，公司发布澄清公告，针对此前有媒体报道称中国证监会已向包括公司在内的38家公司发出补充资讯披露要求一事，明确表示该报道与事实不符且具有误导性，公司自取得中证监备案通知以来未收到任何要求补充资料的通知。此公告有效消除了市场因不实报道而产生的疑虑，推动了股价的修复性反弹。此前，受相关不实报道影响，公司股价曾出现显著下跌，本次澄清公告发布后，市场信心得到恢复，股价随之反弹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fdba71cde34847d28e9e9a8cf892204a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110110332","title":"异动解读｜剂泰科技-P盘中上涨5.07%，澄清未收到中证监补充资料要求提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1110110332","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110110332?lang=zh_cn&edition=full","pubTime":"2026-05-27 10:31","pubTimestamp":1779849086,"startTime":"0","endTime":"0","summary":"5月27日，剂泰科技-P盘中上涨5.07%，报17.2港元，成交额1386.45万港元。消息面上，公司于5月26日发布澄清公告，针对某些媒体报道称中国证监会已向包括公司在内的38家公司发出补充资讯披露要求一事，明确表示该报道与事实不符且具有误导性，公司自取得中证监备案通知以来未收到任何要求补充资料的通知。此前受不实报道影响，股价于5月26日盘中一度大跌逾12%，本次公告有效消除市场疑虑，股价出现修复性反弹。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fdba71cde34847d28e9e9a8cf892204a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":0.1939},{"period":"1month","weight":-0.378},{"period":"3month","weight":0.3838},{"period":"ytd","weight":0.3838}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0531},{"period":"3month","weight":-0.0466},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0138},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"剂泰科技（北京）股份有限公司是一家主要从事人工智能（AI）纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础，涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案，包括AiTEM、AiLNP及AiRNA平台，用以模拟、预测及阐释纳米级别的相互作用关系，从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}